|
|
||||||||
Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7756
Adult respiratory distress syndrome may incorporate in its pathogenesis the hyperplastic proliferation of alveolar epithelial type II cells and derangement in synthesis of pulmonary surfactant. Previous studies have demonstrated that hepatocyte growth factor (HGF) in the presence of serum is a potential mitogen for adult type II cells (R. J. Panos, J. S. Rubin, S. A. Aaronson, and R. J. Mason. J. Clin. Invest. 92: 969-977, 1993) and that it is produced by fetal mesenchymal lung cells (J. S. Rubin, A. M.-L. Chan, D. P. Botarro, W. H. Burgess, W. G. Taylor, A. C. Cech, D. W. Hirschfield, J. Wong, T. Miki, P. W. Finch, and S. A. Aaronson. Proc. Natl. Acad. Sci. USA 88: 415-419, 1991). In these studies, we expand on this possible involvement of HGF in chronic lung injury by showing the following. First, normal adult lung fibroblasts transcribe only small amounts of HGF mRNA, but the steady-state levels of this message rise substantially in lung fibroblasts obtained from animals exposed to oxidative stress. Second, inflammatory cytokines produced early in the injury stimulate the transcription of HGF in isolated fibroblasts, providing a plausible mechanism for the increased amounts of HGF seen in vivo. Third, HGF is capable of significantly inhibiting the synthesis and secretion of the phosphatidylcholines of pulmonary surfactant. Fourth, HGF inhibits the rate-limiting enzyme in de novo phosphatidylcholine synthesis, CTP:choline-phosphate cytidylyltransferase (EC 2.7.7.15). Our data indicate that fibroblast-derived HGF could be partially responsible for the changes in surfactant dysfunction seen in adult respiratory distress syndrome, including the decreases seen in surfactant phosphatidylcholines.
phosphatidylcholine metabolism; protein kinase C; protein kinase A; cytidine 5'-triphosphate:choline-phosphate cytidylyltransferase; adult respiratory distress syndrome
This article has been cited by other articles:
![]() |
A. A. Birukova, I. Cokic, N. Moldobaeva, and K. G. Birukov Paxillin Is Involved in the Differential Regulation of Endothelial Barrier by HGF and VEGF Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marchand-Adam, J. Marchal, M. Cohen, P. Soler, B. Gerard, Y. Castier, G. Leseche, D. Valeyre, H. Mal, M. Aubier, et al. Defect of Hepatocyte Growth Factor Secretion by Fibroblasts in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1156 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mason Hepatocyte Growth Factor . The Key to Alveolar Septation? Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 517 - 520. [Full Text] [PDF] |
||||
![]() |
L. B. Ware and M. A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L924 - L940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jaffre, M. Dehoux, C. Paugam, A. Grenier, S. Chollet-Martin, J.-B. Stern, J. Mantz, M. Aubier, and B. Crestani Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L310 - L315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vivekananda, D. Smith, and R. J. King Sphingomyelin metabolites inhibit sphingomyelin synthase and CTP:phosphocholine cytidylyltransferase Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L98 - L107. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Awasthi and R. J. King PKC, p42/p44 MAPK, and p38 MAPK are required for HGF-induced proliferation of H441 cells Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L942 - L949. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |